Diabetes mellitus has become a massive worldwide problem. In the US, it is the number one biomedical financial burden. Recent analyses reveal that nearly 30 million Americans suffer from diabetes mellitus. The grant will be used for the development of a nanoparticle technology for the treatment of diabetes. This gene therapy could potentially reduce or eliminate the need for insulin therapy or even oral hypoglycemic agents.